Parallax Volatility Advisers
RMD icon

Parallax Volatility Advisers’s ResMed RMD Stock Holding History

Parallax Volatility Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-49,000
Closed -$12M – 2271
2024
Q3 		$12M Buy
+49,000
New +$10.9M 0.02% 482
2023
Q4 		– Sell
-200
Closed -$29.6K – 2445
2023
Q3 		$29.6K Buy
+200
New +$36.2K ﹤0.01% 2058
2022
Q3 		– Sell
-26,200
Closed -$5.49M – 3316
2022
Q2 		$5.49M Buy
+26,200
New +$5.58M 0.01% 941
2021
Q1 		– Sell
-100
Closed -$21K – 2051
2020
Q4 		$21K Sell
100
-300
-75% -$59.8K ﹤0.01% 2099
2020
Q3 		$69K Sell
400
-300
-43% -$55.4K ﹤0.01% 2793
2020
Q2 		$135K Buy
+700
New +$115K ﹤0.01% 2319
2015
Q1 		– Sell
-68,800
Closed -$3.86M – 5307
2014
Q4 		$3.86M Hold
68,800
– – 0.01% 800
2014
Q3 		$3.39M Buy
68,800
+58,800
+588% +$2.99M 0.01% 884
2014
Q2 		$506K Buy
+10,000
New +$496K ﹤0.01% 1381

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Parallax Volatility Advisers's RMD Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of ResMed (RMD) in Q3 2025, closing a stake of 910 shares — an estimated $235K sold.

Parallax Volatility Advisers first reported a position in RMD in Q2 2014 and held it in 19 quarters. The position peaked at $1.01M in Q2 2014. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 910 ResMed shares in Q3 2025, an estimated $235K.
  • Parallax Volatility Advisers first reported a position in ResMed in Q2 2014 and held it in 19 quarters.
  • Parallax Volatility Advisers's ResMed position peaked at $1.01M in Q2 2014.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.